Gut

Rare cause of epigastric distension and vomiting

A 61-year-old Chinese female was admitted with a 1-week history of epigastric pain. She reported recurrent episodes of mild ...
Gut

Macropinocytosis of neutrophil extracellular trap by gastric cancer cells promotes immune escape and peritoneal metastasis

Background Patients with gastric cancer (GC) and peritoneal metastasis (PM) have poor prognoses due to drug resistance and ...
GutOpinion

Deferring first surveillance to 3 years after colorectal ESD is not supported by these data

Qatomah and colleagues conclude that the first surveillance colonoscopy (SC1) after colorectal endoscopic submucosal ...
Gut

Impact of initial severity and progression pattern of new-onset diabetes on pancreatic cancer risk: a 15-year longitudinal nationwide cohort study

Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the ...
gut.bmj

Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification

Background The liver naturally exhibits robust glycosylation processes, yet how aberrant glycosylation affects hepatocellular carcinoma (HCC) and its underlying mechanisms remains poorly understood.
gut.bmj

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening

Department of Surgery, The Chinese University of Hong Kong, China Correspondence to Dr J J Y Sung, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin ...
gut.bmj

Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome

Correspondence to Dr G Nicholas Verne, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112-2699, USA; gverne{at}tulane.edu Background More effective treatments are ...
gut.bmj

P176 Effects of subcutaneous guselkumab induction and maintenance on histologic outcomes in moderate-to-severe crohn’s disease in the phase 3 GRAVITI study

Introduction Guselkumab (GUS) is a dual-acting IL-23p19 subunit inhibitor that was efficacious in double-blind, placebo-controlled, treat-through trials in participants (pts) with moderately to ...
gut.bmj

Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine

Clinical guidelines in the use of fibre supplementation for patients with IBS provide one-size-fits-all advice, which has limited value. This narrative review addresses data and concepts around the ...
gut.bmj

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease

1 Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité, Campus Benjamin Franklin, Berlin, Germany 2 Department of Clinical Physiology, Charité, Campus Benjamin Franklin, ...
gut.bmj

Gut microbiota composition associated with stool consistency

Correspondence to Dr A Zhernakova, Department of Genetics, University of Groningen, University Medical Center Groningen, CB50, P.O. Box 30 001, Groningen 9700 RB, The Netherlands; a.zhernakova{at}umcg ...
gut.bmj

YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...